Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)
Germany
· Delayed Price · Currency is EUR 2.312
+0.024 (1.05%)
At close: Dec 4, 2025
FRA:08HH Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,208 | 7,907 | 7,858 | 11,792 | 15,760 | 15,751 | Upgrade
|
| Market Cap Growth | -4.22% | 0.61% | -33.36% | -25.18% | 0.06% | 89.10% | Upgrade
|
| Enterprise Value | 12,585 | 12,014 | 11,384 | 14,938 | 18,686 | 18,497 | Upgrade
|
| Last Close Price | 2.31 | 1.67 | 1.83 | 2.91 | 3.34 | 3.35 | Upgrade
|
| PE Ratio | 20.89 | 21.57 | 25.82 | 23.30 | 24.08 | 34.34 | Upgrade
|
| PS Ratio | 1.73 | 1.46 | 1.49 | 1.98 | 2.92 | 4.15 | Upgrade
|
| PB Ratio | 1.13 | 1.00 | 1.09 | 1.61 | 2.35 | 2.74 | Upgrade
|
| P/TBV Ratio | 2.98 | 2.73 | 2.89 | 3.99 | 5.83 | 6.40 | Upgrade
|
| P/FCF Ratio | 214.03 | 894.58 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 14.07 | 13.35 | 18.04 | 20.61 | 28.92 | 48.76 | Upgrade
|
| EV/Sales Ratio | 2.62 | 2.21 | 2.15 | 2.51 | 3.46 | 4.87 | Upgrade
|
| EV/EBITDA Ratio | 19.54 | 16.47 | 22.98 | 19.87 | 32.27 | 36.18 | Upgrade
|
| EV/EBIT Ratio | 42.13 | 30.53 | 75.34 | 32.19 | 53.22 | 56.42 | Upgrade
|
| EV/FCF Ratio | 328.18 | 1359.25 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.60 | 0.60 | 0.62 | 0.56 | 0.53 | 0.52 | Upgrade
|
| Debt / EBITDA Ratio | 6.93 | 6.07 | 8.44 | 5.25 | 5.86 | 5.63 | Upgrade
|
| Debt / FCF Ratio | 114.65 | 539.31 | - | - | - | - | Upgrade
|
| Asset Turnover | 0.34 | 0.36 | 0.38 | 0.44 | 0.44 | 0.38 | Upgrade
|
| Inventory Turnover | 2.91 | 2.90 | 3.01 | 3.77 | 3.82 | 3.03 | Upgrade
|
| Quick Ratio | 0.66 | 0.68 | 0.73 | 0.78 | 0.75 | 0.71 | Upgrade
|
| Current Ratio | 0.92 | 0.92 | 1.00 | 1.06 | 1.04 | 1.01 | Upgrade
|
| Return on Equity (ROE) | 6.75% | 6.03% | 5.23% | 7.70% | 10.55% | 9.25% | Upgrade
|
| Return on Assets (ROA) | 1.32% | 1.61% | 0.67% | 2.13% | 1.79% | 2.05% | Upgrade
|
| Return on Capital (ROIC) | 1.60% | 1.98% | 0.84% | 2.70% | 2.21% | 2.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.00% | 3.70% | 1.50% | 4.60% | 4.00% | 4.50% | Upgrade
|
| Earnings Yield | 4.79% | 4.64% | 3.87% | 4.29% | 4.15% | 2.91% | Upgrade
|
| FCF Yield | 0.47% | 0.11% | -3.12% | -1.92% | -0.91% | -1.48% | Upgrade
|
| Dividend Yield | 1.64% | 2.53% | 1.88% | 1.96% | 2.32% | 1.61% | Upgrade
|
| Payout Ratio | 63.02% | 74.35% | 102.89% | 63.64% | 40.48% | 50.09% | Upgrade
|
| Buyback Yield / Dilution | 1.39% | -0.02% | -2.40% | -1.74% | - | - | Upgrade
|
| Total Shareholder Return | 3.03% | 2.51% | -0.52% | 0.22% | 2.32% | 1.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.